These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Kinetics of a carbamazepine-ethosuximide interaction. Warren JW; Benmaman JD; Wannamaker BB; Levy RH Clin Pharmacol Ther; 1980 Nov; 28(5):646-51. PubMed ID: 7438684 [TBL] [Abstract][Full Text] [Related]
6. Valproic acid and ethosuximide slow the onset of maximal dentate activation in the rat hippocampus. Stringer JL Epilepsy Res; 1994 Dec; 19(3):229-35. PubMed ID: 7698099 [TBL] [Abstract][Full Text] [Related]
7. Synergistic anticonvulsant effect of valproic acid and ethosuximide on pentylenetetrazole-induced epileptic phenomena in rats. Musolino R; Gallitto G; De Domenico P; Bonazinga MM; Sturniolo R; Labate C; Di Perri R J Int Med Res; 1991; 19(1):55-62. PubMed ID: 2019316 [TBL] [Abstract][Full Text] [Related]
8. Rapid and simple GLC determination of valproic acid and ethosuximide in plasma of epileptic patients. Riva R; Albani F; Baruzzi A J Pharm Sci; 1982 Jan; 71(1):110-1. PubMed ID: 6799640 [TBL] [Abstract][Full Text] [Related]
9. Effect of sodium valproate and ethosuximide on phenobarbital plasma protein binding. Patsalos PN; Lascelles PT Neurology; 1982 Sep; 32(9):1052-3. PubMed ID: 6810205 [No Abstract] [Full Text] [Related]
10. The absorption and excretion of ethosuximide. Buchanan RA; Kinkel AW; Smith TC Int J Clin Pharmacol; 1973 Apr; 7(2):213-8. PubMed ID: 4731287 [No Abstract] [Full Text] [Related]
11. Efficacy testing of valproic acid compared to ethosuximide in monkey model: I. Dosage regimen design in the presence of diurnal oscillations. Levy RH; Lockard JS; Patel IH; Lai AA Epilepsia; 1977 Jun; 18(2):191-203. PubMed ID: 406138 [No Abstract] [Full Text] [Related]
12. Pharmacokinetics of ethosuximide in the dog. el Sayed MA; Löscher W; Frey HH Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):180-92. PubMed ID: 708147 [TBL] [Abstract][Full Text] [Related]
13. Use of three probes to assess the influence of sex on hepatic drug metabolism. Bachmann KA; Schwartz J; Jauregui L; Sullivan TJ; Martin M Pharmacology; 1987; 35(2):88-93. PubMed ID: 3628465 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of drugs used for petit mal 'absence' epilepsy. Eadie MJ; Tyrer JH; Smith GA; McKauge L Clin Exp Neurol; 1977; 14():172-83. PubMed ID: 99738 [TBL] [Abstract][Full Text] [Related]
17. Drug interactions with valproic acid. Levy RH; Koch KM Drugs; 1982 Dec; 24(6):543-56. PubMed ID: 6818015 [TBL] [Abstract][Full Text] [Related]
18. [Simple gas chromatography determination of valproic acid and ethosuximide in serum]. König H Z Med Lab Diagn; 1985; 26(7):389-92. PubMed ID: 3936295 [No Abstract] [Full Text] [Related]
19. Single sample estimate of ethosuximide clearance. Bachmann K; Schwartz J; Sullivan T; Jauregui L Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):546-50. PubMed ID: 3781674 [TBL] [Abstract][Full Text] [Related]
20. Ethosuximide plasma concentrations: influence of age and associated concomitant therapy. Battino D; Cusi C; Franceschetti S; Moise A; Spina S; Avanzini G Clin Pharmacokinet; 1982; 7(2):176-80. PubMed ID: 6802548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]